Brief: Kaleido Biosciences Reports Q4 Loss Per Share $0.65

Kaleido Biosciences

02/03/2020 12:43

March 2 (Reuters) - Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR
2019
FINANCIAL RESULTS  AND PROVIDES CORPORATE UPDATE
    * Q4 LOSS PER SHARE $0.65
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.34 -- REFINITIV IBES
DATA
    * TOP-LINE DATA EXPECTED IN Q4 2020 FROM PHASE 2 TRIAL OF
KB195
AND CLINICAL STUDY OF KB109
    * ANTICIPATE THAT WE HAVE SUFFICIENT CASH TO EXTEND OUR
RUNWAY
INTO Q1 2021
    * KALEIDO BIOSCIENCES - IN VIVO FINDINGS FROM ONGOING
PROGRAMS IN
IMMUNO-ONCOLOGY AND CARDIOMETABOLIC AND LIVER DISEASES ALSO
EXPECTED IN Q4 2020

Source text for Eikon:  ID:nGNX454xxP 
Further company coverage:  KLDO.O 

 ((Reuters.Briefs@thomsonreuters.com;))